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The filamentous fungus Aspergillus fumigatus produces a variety of enzymes and toxins that may
facilitate fungal colonization of tissue and evasion of the host immune response. One such toxin,
fumagillin, was investigated for its ability to inhibit the action of neutrophils, which are a central
component of the innate immune response to microbial infection. Neutrophils exposed to 2 mg
fumagillin ml”1 for 25 min showed a significantly reduced ability to kill yeast cells (P,0.02), to
phagocytose conidia of A. fumigatus (P,0.023) and to consume oxygen (P,0.032). The ability of
neutrophils to generate superoxide is dependent upon the action of a functional NADPH oxidase
complex which is composed of cytosolic (p40phox, p47phox, p67phox, Rac2) and membrane
(gp91phox) proteins. Exposure of neutrophils to fumagillin inhibited the formation of the NADPH
oxidase complex by blocking the translocation of p47phox from the cytosolic to the membrane
fraction (P50.02). In addition to the production of superoxide, neutrophils also undergo
degranulation, which leads to the release of proteolytic enzymes that contribute to the
microbicidal activity of the cell. Fumagillin-treated neutrophils showed reduced degranulation as
evidenced by lower myeloperoxidase activity (P,0.019). Fumagillin-treated cells demonstrated
reduced levels of F-actin, thus indicating that retarding the formation of F-actin may contribute to
the inhibition of the structural rearrangements required in the activated neutrophil. This work
indicates that fumagillin may contribute to reducing the local immune response by altering the
activity of neutrophils and thus facilitate the continued persistence and growth of A. fumigatus in
the host.
INTRODUCTION
The filamentous fungus Aspergillus fumigatus is a signific-
ant cause of disease in immunocompromised patients and
is responsible for up to 4% of deaths in tertiary hospitals in
Europe (Brookman & Denning, 2000). A variety of toxins
and enzymes produced by A. fumigatus may facilitate
growth within the host and impair the host’s immune
response (Tekaia & Latge´, 2005). One of the most widely
studied toxins, gliotoxin, can retard the ciliary beat
frequency within the lung (Amitani et al., 1995), induce
apoptosis in cells of the immune system (Sutton et al.,
1994; Orciuolo et al., 2007), exacerbate invasive aspergil-
losis (Sutton et al., 1996) and disrupt the formation
of a functional NADPH oxidase complex in neutrophils
(Tsunawaki et al., 2004).
The toxin fumagillin (C26H34O7; 458.6 Da) is also pro-
duced by A. fumigatus upon hyphal development (Mitchell
et al., 1997). Early work characterized the amoebicidal
properties of this compound (McCowen et al., 1951) and
recently fumagillin has been identified as an inhibitor of
angiogenesis through the covalent interaction of methio-
nine aminopeptidase-2 (MetAP-2), a feature which is
shared with its drug target analogue TNP-470 (Ingber
et al., 1990). Fumagillin can retard the ciliary beat
frequency of pulmonary epithelial cells; however, its effect
is not as significant as that induced by gliotoxin (Amitani
et al., 1995).
Fumagillin has undergone clinical trials as an oral
treatment for intestinal microsporidiasis in patients with
HIV infection but adverse effects such as thrombocyto-
penia, neutropenia, hyperlipasaemia and abdominal
cramps were recorded (Molina et al., 2000). Successful
therapeutic use of fumagillin has been reported when
applied topically in cases of microsporidial keratocon-
junctivitis in humans (Diesenhouse et al., 1993). The
fumagillin dicyclohexamine salt was found to induce sister
chromatid exchanges at doses as low as 0.34 mg ml21 in
human peripheral blood lymphocytes (Stevanovic et al.,
2008).
Abbreviations: MPO, myeloperoxidase; PMA, phorbol 12-myristate
13-acetate.
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Neutrophils provide the first line of defence of the innate
immune system by phagocytosing, killing and digesting
bacteria and fungi (Bellocchio et al., 2004). Degradation of
the ingested microbe occurs in the phagocytic vacuole by a
combination of oxidative and non-oxidative mechanisms.
Oxidative mechanisms refer to microbial killing that is
dependent upon the production of reactive oxygen species,
triggered by activation of the NADPH oxidase (Curnutte
et al., 1987), which causes the single electron reduction of
oxygen to superoxide anion (O
{:
2 ) (Babior et al., 1973).
The active oxidase is a multicomponent system involving
flavocytochrome b558. A number of cytosolic proteins are
also required to activate the flavocytochrome b, includ-
ing p67phox, p47phox and the small GTP-binding protein
Rac in the GTP-bound form (Standish & Weiser, 2009;
Wallach & Segal, 1996). These cytosolic components,
together with amphiphiles such as sodium dodecyl
sulphate and membrane fractions, or pure flavocyto-
chrome, induce electron transport in vitro in what is
known as the cell-free system (Curnutte et al., 1987; de
Mendez & Leto, 1995). Translocation of the cytosolic
components of the NADPH oxidase (p40phox, p67phox,
p47phox and Rac) to the membrane component is required
to produce a functional complex capable of producing
superoxide (Sumimoto et al., 1996; Tsunawaki et al., 2004;
Wientjes et al., 1993). The syndrome of chronic granulo-
matous disease (CGD) provides the most definitive
evidence for the clinical importance of the NADPH
oxidase as CGD is characterized by predisposition to
bacterial and fungal infection and an absence of NADPH
oxidase activity (Thrasher et al., 1994).
The antimicrobial systems of neutrophils which can
operate in the absence of oxygen are due to neutral
serine proteases, hydrolytic enzymes and cationic pro-
teins. These proteolytic enzymes are packaged within
cytoplasmic granules that are released upon cell activation
(Spitznagel, 1990). Myeloperoxidase (MPO) is a com-
ponent of primary granules and in the presence of
hydrogen peroxide produces hypochlorous acid. Defects
associated with neutrophil granules include the inherited
granule deficiency Che´diak–Higashi syndrome, which is
a rare autosomal recessive disorder associated with a
prominent defect in formation of neutrophil granules
resulting in increased susceptibility to infection (Malech
& Nauseef, 1997).
It has been established that gliotoxin inhibits the action of
neutrophils by blocking the translocation of p47phox and
p67phox from the cytosolic fraction to the membrane
fraction (Tsunawaki et al., 2004). The aim of the work
presented here was to establish the effect of fumagillin on
human neutrophils since its production in the body by A.
fumigatus could retard this element of the immune
response and facilitate the growth and persistence of the
fungus. Furthermore, the inhibition of neutrophil function
mediated by fungal toxins could be responsible for
enhanced bacterial and/or fungal colonization and disrup-
tion of the host immune response.
METHODS
Chemicals. All chemicals and reagents were of the highest purity and
were purchased from Sigma Aldrich unless stated otherwise.
Fumagillin (1 mg ml21) was prepared in a sterile environment by
dissolving in HPLC-grade methanol and serially diluting in PBS to
2 mg ml21.
Fungal strains. Candida albicans, isolate MEN, was cultured in
YEPD broth [2% (w/v) glucose, 2% (w/v) bactopeptone (Difco
Laboratories), 1% (w/v) yeast extract (Oxoid)] at 30 uC and
200 r.p.m. in an orbital incubator. Stocks were maintained on
YEPD agar plates (as above but supplemented with 2%, w/v, agar). A.
fumigatus ATCC 26933 was obtained from the American Type
Culture Collection and was grown on malt extract agar (Difco
Laboratories).
Isolation of conidia. A. fumigatus conidia were isolated by washing
plates in PBS containing 0.1% Tween 80. Following centrifugation at
5000 g for 10 min, the conidial pellet was washed three times in PBS
to remove excess Tween. Conidial number was ascertained by
haemocytometry.
Preparation of human neutrophils. Human neutrophils were
isolated from healthy volunteers (ethical permission granted by NUI
Maynooth Ethics Committee), and separated from blood collected in
10 ml heparinized tubes (BD Vacutainer Systems) under vacuum
by dextran sedimentation and Ficoll-Hypaque (Axis-Shield PoC
AS) centrifugation as previously described (Reeves et al., 2002).
Erythrocytes were removed by hypotonic lysis in water and brought
back to osmolarity using a 1.8% (w/v) NaCl solution. The cells were
resuspended in PBS (pH 7.4) containing 5 mM glucose and used
immediately. Viability was assessed using the trypan blue exclusion
assay (Eichner et al., 1986).
In vitro phagocytosis and killing of pathogenic targets by
human neutrophils. Neutrophils (16107 ml21) were incubated in
the presence of 2 mg fumagillin ml21 for 25 min at 37 uC. A.
fumigatus conidia were opsonized using human serum for 45 min at
37 uC. Phagocytosis was measured by incubating pre-treated
neutrophils (16107) with opsonized A. fumigatus conidia
(26107) in a stirred thermally controlled chamber at 37 uC in a
final volume of 1 ml. An aliquot was removed immediately after the
addition of conidia to the cells (t50), and after a further 30, 60 and
120 min of incubation. The viability of neutrophils before
(98.1±2.2%) and after (94.5±1.5%) the phagocytosis assay did
not change significantly (P50.6). Three hundred neutrophils were
counted and the number of cells containing phagocytosed conidia
was ascertained microscopically. The mean number±standard error
was calculated.
Assays to determine the effect of 2 mg fumagillin ml21 on the
microbicidal activity of neutrophils (16107) employed serum-
opsonized C. albicans at a target ratio of 56106 to 16107 neutrophils
in a final volume of 1 ml. An aliquot was removed at 0, 20, 40 and
60 min, serially diluted in ice-cold minimal essential medium (Sigma
Aldrich) to quench phagocytosis and plated on YEPD plates to
ascertain viability. The percentage reduction in viability of C. albicans
was calculated based upon the viability of yeast cells at t50 (Reeves
et al., 2002).
Determination of oxygen consumption. Oxygen consumption was
measured in a temperature-controlled (37 uC) chamber that was
attached to a Clark-type oxygen electrode based on the fact that the
oxygen content of PBS at 37 uC is 230 nmol ml21 (Segal & Coade,
1978). Neutrophils (16107) were pre-treated with 2 mg fumagillin
ml21 for 25 min at 37 uC and 16107 cells were placed in the
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thermally controlled stirred chamber and stimulated with 1 mg
phorbol 12-myristate 13-acetate (PMA) ml21.
Subcellular fractionation of neutrophils. Neutrophils (16108
ml21) were stimulated with PMA (1 mg ml21) in the presence of 2 mg
fumagillin ml21. Following treatment, cells were pelleted by
centrifugation and resuspended in 200 ml Breaks buffer [10 mM
KCl, 3 mM NaCl, 4 mM MgCl2, 10 mM piperazine-N,N9-bis(2-
ethanesulfonic acid); pH 7.2] (Reeves et al., 2002) containing protease
inhibitors (10 mg ml21 leupeptin, pepstatin A, aprotinin and Na-p-
tosyl-L-lysine chloromethyl ketone hydrochloride), sonicated
(Bandelin Sonopuls; Bandelin Electronics) three times for 5 s at
20% power, and centrifuged at 200 g for 10 min at 4 uC. The post-
nuclear supernatant was centrifuged at 100 000 g for 1 h at 4 uC in a
Beckman SW60 TI rotor. Following centrifugation, the membrane
pellet was solubilized in 2% Triton X-100, 150 mM NaCl, 1% (w/v)
sodium deoxycholate for 1 h at 4 uC. The solubilized fraction was
centrifuged at 7000 g to remove any membrane debris (Renwick et al.,
2007). Bradford Protein Assay reagent (Bio-Rad Laboratories) was
used to assay the amount of protein in each fraction, using BSA as a
standard.
Degranulation of neutrophils. Neutrophils (56107 ml21) were
pre-treated for 25 min in the presence of 2 mg fumagillin ml21 at
37 uC and resuspended in PBS containing 5 mM glucose and protease
inhibitors as described above. Following PMA (1 mg ml21) stimu-
lation in a stirred chamber, an aliquot was removed at 0, 3, 6 and
9 min. Cells were removed by centrifugation (800 g). The protein
content of the supernatant was precipitated and prepared for
electrophoresis and immunoblotting.
MPO activity assay. Quantification of MPO activity was ascertained
using a standard activity assay (Invitrogen EnzChek) and used
according to the manufacturer’s specifications. Briefly, 50 ml cell-free
supernatant (10 mg protein) was assessed for peroxidation activity by
addition to 100 ml 26 Amplex UltraRed reagent. The non-fluorescent
substrate is oxidized by H2O2 redox intermediates of MPO to form a
fluorescent product. Fluorescence intensity was read at excitation
530 nm and emission at 590 nm. Fluorescence was recorded using a
Synergy HT microplate reader (BioTek).
Quantification of F-actin assembly. Neutrophils (56107) were
incubated in the presence or absence of fumagillin at 37 uC as
described above. Following PMA stimulation (1 mg ml21), neutro-
phils were pelleted, resuspended in Breaks buffer and lysed by
sonication. Following centrifugation at 200 g for 10 min at 4 uC, the
supernatant was removed and prepared for electrophoresis and
immunoblotting with anti-F-actin polyclonal antibody.
Electrophoresis and immunoblotting. Samples were separated by
SDS-PAGE (12.5%, w/v, acrylamide), and protein profiles were
visualized by colloidal Coomassie staining. For Western blotting, the
protein was transferred to a nitrocellulose membrane using a wet
blotter at 100 V for 70 min. Rabbit polyclonal antisera raised against
human p47phox were used at a dilution of 1/2000 for 1 h. MPO
antiserum raised in rabbit (Genway) was used at a dilution of 1/650
overnight at 4 uC. F-actin antisera raised in mouse (Millipore) were
used at a dilution of 1/3000 overnight at 4 uC. Secondary antibody
employed horseradish peroxidase-linked rabbit antisera at a dilution
of 1/2000, or horseradish peroxidase-linked mouse antisera at a
dilution of 1/2500. Enhanced chemiluminescence (Pierce Bio-
technology) was employed to develop reactive protein bands and
immuno-bands were quantified by densitometry using ImageQuant
software.
Immunofluorescence. Immunofluorescence microscopy was per-
formed as described previously (Renwick et al., 2007). Cells were fixed
with 4% (v/v) paraformaldehyde, permeabilized with 0.2% (v/v)
Triton X-100 and blocked with 10 mM NaBH4. The cells were
incubated with primary antibody against p47phox or against MPO
(Genway) overnight at 4 uC. The slides were washed in PBS and
incubated with tetramethylrhodamine isothiocyanate goat anti-rabbit
IgG secondary antibody (The Jackson Laboratory) for 1 h. The
controls for this experiment included cells alone and cells exposed to
secondary antibody. For rhodamine-coupled phalloidin staining,
neutrophils were fixed and permeabilized as described previously and
incubated with 0.8 mM rhodamine-coupled phalloidin overnight at
4 uC. The slides were washed three times in PBS and viewed with an
Olympus FluoView 1000 confocal microscope.
Statistics. All values are the mean of at least three independent
determinations±SD. Experimental data were tested for statistical
significance at P,0.05 using a Students t-test (Minitab 14 package).
RESULTS
Fumagillin inhibits phagocytosis and killing by
purified neutrophils
Previous work that examined the interaction of fumagillin
with human neutrophils employed concentrations of up to
128 mg fumagillin ml21 and an exposure time of 7 min
(Tsunawaki et al., 2004). In this work, we employed a
fumagillin concentration which did not affect neutrophil
viability. Neutrophils were incubated in the presence of 1
or 2 mg fumagillin ml21 for 25 min prior to mixing with
opsonized C. albicans cells in a ratio of 2 : 1 neutrophils to
yeast at 37 uC. Aliquots of cells were removed, serially
diluted in ice-cold minimal essential medium and plated
onto YEPD agar plates in order to establish the viability of
yeast cells in the chamber. The results indicate (Fig. 1) that
neutrophils pre-incubated in the presence of methanol
killed 94.71±4.32% of C. albicans cells in 60 min.
Neutrophils that had been pre-exposed to 1 mg fumagillin
ml21 showed no significant difference in the rate of killing
compared to solvent-treated neutrophils (P50.6). In
contrast, those cells that had been exposed to 2 mg
fumagillin ml21 showed a rate of killing similar to that
of the control up to 20 min (P50.247) but thereafter the
rate of killing was greatly reduced. At 60 min, 58.1±7.4%
of C. albicans cells had been killed, which was significantly
less than that achieved by the control cells at P,0.02.
Based on the above results, 2 mg fumagillin ml21 was
chosen for subsequent analysis as being the lowest
concentration capable of eliciting a response. To investigate
the effect of fumagillin on the process of neutrophil
phagocytosis, cells were exposed to 2 mg fumagillin ml21
for 25 min at 37 uC prior to incubation with serum-
opsonized A. fumigatus conidia at a ratio of 1 : 2 neu-
trophils to conidia. Samples were removed periodically and
the number of conidia internalized in neutrophils was
assessed microscopically. The results (Fig. 2) demonstrate
that phagocytosis was significantly reduced in neutrophils
that had been exposed to fumagillin compared to the
untreated or methanol-treated cells. At 120 min, 32.86±
1.1% of fumagillin-treated neutrophils demonstrated
Fumagillin and neutrophil function
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phagocytosis of conidia while 46.02±0.736% of the
solvent (control)-treated cells showed phagocytosis
(P50.015).
Oxygen consumption
The consumption of oxygen is essential for the micro-
bicidal activity of neutrophils as oxygen is converted to
O
{:
2 by the action of the NADPH oxidase complex in
activated cells (Segal & Jones, 1978). The oxygen consump-
tion rate of PMA (1 mg ml21)-stimulated neutrophils
(16107 ml21) was measured using a Clark-type oxygen
electrode as described in Methods. Control cells and
those exposed to the solvent consumed 95.85±8.97 nmol
oxygen ml21 within 10 min (Fig. 3). In contrast, neu-
trophils that had been exposed to 2 mg fumagillin ml21 for
25 min prior to PMA stimulation consumed 29.06±
11.78 nmol oxygen ml21 over the same period, a reduction
which is significant relative to the control at P50.017.
Modulatory effect of fumagillin on NADPH
oxidase complex formation
The NADPH oxidase complex consists of a number of
proteins and a subset of these (p40phox, p47phox, p67phox
and Rac) is located in the cytosol in unstimulated
neutrophils but translocates to the membrane to form a
functional complex in stimulated cells (Fuchs et al., 1995,
1996). The membrane fractions of fumagillin-treated and
control neutrophils were isolated, resolved by 1-D SDS-
PAGE, blotted and probed with anti-p47phox antibody as
described in Methods. Untreated neutrophils showed
significantly less p47phox in the membrane fraction
compared to PMA-stimulated cells (P50.011). The results
demonstrated (Fig. 4) a large amount of p47phox in the
membrane fraction of PMA-treated cells and in those
which had been exposed to the solvent prior to PMA
stimulation (P50.022). Those cells that had been exposed
to 2 mg fumagillin ml21 showed a level of p47phox in the
membrane fraction that was significantly lower (P50.026)
than that in PMA-stimulated cells. The translocation event
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Fig. 1. Fumagillin inhibits the ability of neutrophils to kill yeast
cells. Neutrophils (1107) were pre-treated in the presence or
absence of fumagillin (2 mg or 1 mg ml”1), or in the presence of
0.2% (v/v) methanol for 25 min at 37 6C. After washing,
neutrophils were incubated with opsonized C. albicans (5106)
in a stirred, thermostatically controlled chamber. Aliquots were
periodically removed and serially diluted in ice-cold MEM to
quench phagocytosis. A diluted sample (100 ml) was spread onto
a YEPD agar plate and incubated at 30 6C. Percentage reduction
in viability was calculated based upon the viability at t50. X,
Methanol control; h, 2 mg fumagillin ml”1; m, 1 mg fumagillin ml”1;
&, PBS. The data are representative of three independent
experiments. *Difference between 2 mg fumagillin ml”1 treatment
and control at P,0.02.
40
20
0
**
*
60
60300 120
Time of exposure (min)  
P
ha
go
cy
to
si
ng
 
ce
lls
 (%
)
Fig. 2. Effect of fumagillin on in vitro phagocytosis by neutrophils.
Neutrophils (1107) were incubated in the presence of 2 mg
fumagillin ml”1 as described in Methods and incubated with
serum-opsonized A. fumigatus conidia. Aliquots were removed
periodically and examined by light microscopy to determine the
level of phagocytosis. X, PBS; &, methanol control; m, 2 mg
fumagillin. *Difference between methanol and fumagillin treatments
at P50.015. **Difference between PBS and fumagillin treatments
at P50.023.
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Fig. 3. Fumagillin inhibits the ability of neutrophils to consume
oxygen. Neutrophils (1107) were incubated in the presence or
absence of 2 mg fumagillin ml”1, washed and stimulated with 1 mg
PMA ml”1. The rate of oxygen depletion in the chamber was
monitored over a 10 min period. Cells which had been pre-treated
with fumagillin (m) showed reduced ability to consume oxygen
relative to PBS (X) (*P50.032) and methanol (&) (**P50.017)
controls. The data presented are representative of four independ-
ent experiments.
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was also visualized by immunofluorescence microscopy
using anti-p47phox antibody and a fluorescently labelled
secondary antibody as described in Methods. The fluor-
escence in unstimulated cells was widely distributed
throughout the cytoplasm (Fig. 5). In cells that were
PMA-stimulated, the fluorescence was located in a zone
around the cell’s inner perimeter with a small amount of
fluorescence remaining within the cytoplasm. Cells that
had been exposed to fumagillin prior to PMA stimulation
showed some concentration of fluorescence around the
cell perimeter but also retained fluorescence within the
cytoplasm. These results indicate that cells exposed to
fumagillin showed reduced levels of translocation of
p47phox to the membrane fraction of neutrophils and this
could hinder the formation of an active NADPH oxidase
complex in cells.
Fumagillin inhibits degranulation of stimulated
neutrophils
The production of superoxide by PMA-stimulated neu-
trophils is associated with degranulation and the release
of proteolytic enzymes into the phagocytic vacuole and
around the cell perimeter (Standish & Weiser, 2009).
Degranulation was measured by stimulating neutrophils
with PMA in a stirred, thermally controlled chamber for
6 min and centrifuging the cell pellet at 800 g. The
supernatants from cells were resolved by SDS-PAGE,
blotted and probed with anti-human MPO antibody. The
results demonstrate (Fig. 6) that the amount of MPO
released by neutrophils that were previously exposed to
fumagillin was significantly reduced compared to that
released by control cells (P50.035). The peroxidation
activity of MPO from these supernatants was assessed as
described in Methods. The results (Fig. 7) indicate a
significant increase in peroxidation activity where PMA
stimulation was employed. However, there was a signific-
ant decrease in the level of peroxidation activity evident
when neutrophils were pre-treated with fumagillin and
subsequently PMA-stimulated, relative to the PMA only
and solvent control (P50.019 and 0.012, respectively).
These results indicate that fumagillin reduced neutrophil
degranulation but did not completely block the process.
Fumagillin retards F-actin reassembly
Actin in unstimulated neutrophils exists in the G form but
upon stimulation it is converted to the F form in order for
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Fig. 4. Fumagillin inhibits the translocation of
p47phox from the cytosol to the membrane.
Neutrophils (1108) were incubated in the
presence or absence of 2 mg fumagillin ml”1
and fractionated as described in Methods. The
cytosolic and membrane components were
subjected to electrophoresis and immunoblot-
ting. Densitometry was used to quantify the
relative band intensity of the reactive mem-
brane-bound p47phox band. Membrane-bound
p47phox was found to be reduced relative to
PMA alone (P50.022), and 0.2% methanol
incubation with PMA stimulation (P,0.05).
The data are representative of results obtained
from three independent experiments. UT,
Untreated cells.
Arrow indicates translocation
to the membrane
Resting PMA
Fumagillin
and PMA
Fig. 5. Visualization of p47phox in neutrophils.
Neutrophils were incubated in the presence of
2 mg fumagillin ml”1 for 25 min, washed, PMA-
stimulated, fixed and permeabilized as
described in Methods. Untreated cells showed
a wide dispersal of p47phox compared to PMA-
stimulated cells, which showed a high level of
translocation to the membrane. Neutrophils
which had been incubated with fumagillin
showed some translocation to the membrane
but retained most p47phox in the cytosol.
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phagocytosis, cytosolic protein translocation and degranu-
lation to occur (Comera et al., 2007). Disruption of the
conversion of actin from the G to the F form could be
responsible for many of the effects observed here as the
failure to produce sufficient F-actin would retard p47phox
translocation, phagocytosis and degranulation.
In order to quantify the effect of fumagillin on F-actin
assembly, neutrophils were exposed to the toxin as
described in Methods, and protein was extracted and
separated by SDS-PAGE. Immunoblotting was employed
in conjunction with densitometry of reactive bands speci-
fic for F-actin. The results (Fig. 8) show a significant
decrease in the level of reactivity to F-actin specific anti-
body where neutrophils were exposed to fumagillin in
conjunction with PMA stimulation compared to both
PMA only and methanol in conjunction with PMA
stimulation (P¡0.05).
Untreated neutrophils and those pre-exposed to fumagillin
prior to PMA stimulation were stained with rhodamine-
coupled phalloidin, which is specific for F-actin (Comera
et al., 2007), and cells were examined by immunofluores-
cence microscopy. The results (Fig. 9) indicate that in
untreated cells, there was a small amount of fluorescence,
whereas in PMA-treated cells, the level of fluorescence was
greatly increased corresponding to the elevated levels of
F-actin in these cells (Comera et al., 2007). The level of
fluorescence in cells that had been pre-treated with
fumagillin prior to PMA stimulation was greater than that
in the untreated cells but less than that evident in PMA-
treated cells. These results suggest that there is a lower level
of F-actin in neutrophils that have been exposed to
fumagillin.
DISCUSSION
A. fumigatus is a serious pathogen of immunocompromised
patients, where it can induce a variety of potentially life-
threatening diseases (Brookman & Denning, 2000). The
production and secretion of hydrolytic enzymes and toxins
by this fungus appears to play a key role in its ability to
colonize host tissue and to neutralize the immune response
(Rementeria et al., 2005). Fumagillin is produced by A.
fumigatus but its role in facilitating colonization or
suppressing immune function has not been fully elucidated.
The aim of this work was to examine the interaction of this
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Fig. 6. Fumagillin inhibits neutrophil degranu-
lation. Neutrophils (5107) were incubated in
the presence of 2 mg fumagillin ml”1 for
25 min and placed in a stirred chamber at
37 6C. Six minutes following PMA stimulation
the contents of the chamber were centrifuged
at 800 g for 5 min and the supernatant was
prepared for electrophoresis and immunoblot-
ting. Reactive bands were used to quantify the
effect of fumagillin on degranulation using
densitometry. Neutrophils which had been
exposed to fumagillin and stimulated with
1 mg PMA ml”1 showed a reduction in the
level of degranulation of MPO relative to
untreated cells (P,0.001) and the solvent/
PMA cells (P,0.035). Data presented here
are representative of the results of five
independent experiments. UT, Untreated cells.
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Fig. 7. Fumagillin inhibits the release of MPO. Neutrophils
(5107) were incubated in the presence of 2 mg fumagillin ml”1
for 25 min and placed in a stirred chamber at 37 6C. Six minutes
following PMA stimulation the contents of the chamber were
removed and centrifuged at 800 g for 5 min. Protein (10 mg)
was incubated in the presence of 100 ml 2 Amplex UltraRed
working solution and the fluorescence intensity was read at
excitation 530 nm and emission at 590 nm. Difference in MPO
peroxidation value of solvent/PMA-treated cells relative to
fumagillin/PMA-treated cells at P5¡0.019. PMA-treated cells
relative to solvent/PMA-treated cells P50.924. UT, Untreated
cells.
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toxin with neutrophils, which are a key component of the
innate immune response. Tsunawaki et al. (2004) previously
examined the interaction of A. fumigatus toxins with
neutrophils and demonstrated an inhibition of p47phox
and p67phox translocation in gliotoxin-treated cells. In
their work, the response of neutrophils to fumagillin at
concentrations up to 125 mg ml21 was assessed and no
significant change in neutrophil function (i.e. superoxide
production) was noted at concentrations up to 64 mg ml21.
Interestingly, Amitani et al. (1995) demonstrated complete
ciliostasis and epithelial cell disruption at 10 mg fumagillin
ml21, and in the work presented here, neutrophils were
exposed to a significantly lower concentration of fumagillin
which did not affect the cell viability.
The results presented here indicate that exposure to 2 mg
fumagillin ml21 retards the ability of human neutrophils to
phagocytose and kill microbial cells. This appears to be
mediated through an inhibition of p47phox translocation
leading to a reduction in NADPH oxidase activity and to a
diminution in neutrophil degranulation. Upon stimulation,
neutrophils undergo a series of structural and functional
rearrangements to enable the killing of ingested microbes,
which is made possible by the conversion of G-actin to
F-actin in order to facilitate the internal rearrangements
(Misu et al., 2009). This work demonstrates that fumagillin
may act by retarding the conversion of G to F actin and as a
consequence this could hinder the other structural altera-
tions associated with neutrophil activation.
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Fig. 8. Fumagillin inhibits the formation of F-
actin. Neutrophils (5107) were incubated in
the presence or absence of 2 mg fumagillin
ml”1, and stimulated with 1 mg PMA ml”1,
washed and resuspended in Breaks Buffer.
Following lysis, cells were prepared for elec-
trophoresis and immunoblotting as described
in Methods. Untreated cells showed a back-
ground level of F-actin; however, following
PMA stimulation or methanol incubation fol-
lowed by PMA stimulation, cells showed
increased F-actin reactivity. Cells which had
been exposed to fumagillin prior to PMA
stimulation showed a slight increase in F-actin
relative to untreated cells (P50.05) but this
reactivity was reduced compared to the
positive controls (PMA and solvent/PMA)
(P,0.05). Densitometry was used to quantify
band reactivity and the data presented here
are representative of four independent experi-
ments. UT, Untreated cells.
Resting cell PMA-stimulated Fumagillin and PMA
Fig. 9. Visualization of rhodamine-coupled phalloidin staining of F-actin in neutrophils. Neutrophils were prepared as described
in Methods and viewed by confocal microscopy. Untreated cells showed a low level of fluorescence relative to the increased
fluorescence in PMA-treated cells, which was highly localized as indicated by the arrow. Fumagillin-treated cells which had
been stimulated with PMA showed some reactivity but this was greatly reduced relative to the positive control.
Fumagillin and neutrophil function
http://jmm.sgmjournals.org 631
The translocation of the cytosolic components of the
NADPH oxidase complex of neutrophils to the membrane
component is essential for the activation of the NADPH
oxidase complex (Reeves et al., 2002). This translocation
event can be monitored by quantifying the amount of
p40phox, p47phox or p67phox located in the membrane
fraction of stimulated neutrophils (Renwick et al., 2007). In
stimulated cells, p47phox interacts with p67phox via the
simultaneous binding of the p67phox C-terminal SH3
domain to both the proline-rich region of amino acid
residues 360–369 and the C-terminally flanking region of
p47phox. The coupled proteins then translocate as a single
unit to the membrane, hence measuring the translocation
of p47phox is a useful indicator of the translocation of the
p47phox–p67phox unit (Mizuki et al., 2005). Neutrophils
exposed to fumagillin prior to PMA stimulation demon-
strated a reduction in the translocation of p47phox by
approximately 50% relative to the control (Fig. 4). This
reduction in translocation is also evident by immuno-
fluorescence, where high levels of translocation are evident
in PMA-stimulated cells, which show a clearance of
immunofluorescence from the centre of the cell, indicating
that the p47phox has migrated to the cell periphery (Fig. 5).
Lower levels of p47phox translocation are apparent in those
cells that had been pre-treated with fumagillin; however,
some is evident, indicating a reduction in translocation
rather than a complete inhibition of this process.
The process of degranulation results in the release of
hydrolytic enzymes into the phagocytic vacuole and
around the periphery of the cell and is an essential element
of the neutrophil’s ability to kill ingested micro-organisms
(Spitznagel, 1990). PMA-stimulated cells underwent degra-
nulation as evident by the large amount of MPO detected
by Western blotting in the cell-free supernatant (Fig. 6). In
contrast, neutrophils that had been pre-exposed to
fumagillin showed levels of MPO release approximately
20% less than those of the PMA-treated cells. MPO
peroxidation activity was also reduced in fumagillin/PMA-
treated neutrophils relative to that evident in solvent/PMA
or PMA-treated cells (Fig. 7).
The conversion of actin from the G form to the F form
upon stimulation is central to the morphological and
functional changes that occur within neutrophils and can
be visualized by fluorescence of F-actin by rhodamine-
coupled phalloidin. Previous research into mycotoxin-
mediated inhibition of neutrophil function has shown that
gliotoxin induces a pronounced change in the neutrophil
structure at the F-actin level with notable collapse around
the nucleus, leading to cell shrinkage (Comera et al., 2007).
The F-actin levels in fumagillin-treated neutrophils were
significantly lower than those in PMA or solvent/PMA-
treated cells at P,0.05 (Fig. 8). This is also apparent by
immunofluorescence, where reduced fluorescence is evid-
ent in fumagillin-treated neutrophils, indicating lower
amounts of F-actin in these cells (Fig. 9). Interestingly, it
has been reported previously that the mycotoxin cytocha-
lasin D (1 mM) induced significant rearrangements in F-
actin of neutrophils and membrane retraction (Yu¨ru¨ker &
Niggli, 1992).
Previous work has indicated that growing colonies of A.
fumigatus produce and secrete a range of metabolites that
diffuse in advance of the growing hyphae and cause cell
death and detachment (Daly & Kavanagh, 2002). The
ability of A. fumigatus to produce a variety of toxins may
assist it in suppressing the local immune response
(Rementeria et al., 2005) and enable growth over and
through tissue (Amitani et al., 1995; Sutton et al., 1996).
While great strides have been made in recent years in
understanding the molecular biology of A. fumigatus
(Brakhage & Langfelder, 2002; Brookman & Denning,
2000), much remains to be discovered about the inter-
action of the pathogen with the host and in particular how
secreted enzymes and toxins (Rementeria et al., 2005)
facilitate the growth of the fungus in the body and enable it
to withstand the immune response. The work presented
here demonstrates that concentrations of fumagillin that
do not adversely affect viability can retard the activity of
neutrophils and this has the potential to facilitate fungal
persistence and colonization in vivo. The presence of
fumagillin-producing strains of A. fumigatus in the lung
may have a secondary effect in colonized patients. The
ability of fumagillin to retard the activity of neutrophils
may contribute to the increased levels of bacterial diseases
evident in the lungs of cystic fibrosis patients and others
with pre-existing pulmonary malfunction (Festini et al.,
2006; Duff et al., 2006). It is possible that mycotoxins, such
as fumagillin, may impair local immunity to such a degree
as to facilitate the development of secondary infections
without significantly improving the environment for the
growth of A. fumigatus.
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